{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:06:54Z","timestamp":1785557214209,"version":"3.56.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"DOI":"10.7759\/cureus.95914","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:39:08Z","timestamp":1762033148000},"source":"Crossref","is-referenced-by-count":1,"title":["Role of the Genetic Variants of Fetuin-A and Adiponectin in Type 2 Diabetes Mellitus: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Huma","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mustufa","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v14.i3.130","article-title":"Pancreatic \u03b2-cell dysfunction in type 2 diabetes: implications of inflammation and oxidative stress","volume":"14","author":"Dludla PV","year":"2023","unstructured":"Dludla PV, Mabhida SE, Ziqubu K, et al.. Pancreatic \u03b2-cell dysfunction in type 2 diabetes: implications of inflammation and oxidative stress. World J Diabetes. 2023, 14:130-46. 10.4239\/wjd.v14.i3.130","journal-title":"World J Diabetes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi P","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, et al.. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019, 157:107843. 10.1016\/j.diabres.2019.107843","journal-title":"Diabetes Res Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/mend.7.11.7906861","article-title":"Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level","volume":"7","author":"Srinivas PR","year":"1993","unstructured":"Srinivas PR, Wagner AS, Reddy LV, Deutsch DD, Leon MA, Goustin AS, Grunberger G. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol. 1993, 7:1445-55. 10.1210\/mend.7.11.7906861","journal-title":"Mol Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90098-6","article-title":"Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity","volume":"58","author":"Auberger P","year":"1989","unstructured":"Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, Rossi B, Le Cam A. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell. 1989, 58:631-40. 10.1016\/0092-8674(89)90098-6","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1992.tb16663.x","article-title":"The nucleotide and partial amino acid sequences of rat fetuin: identity with the natural tyrosine kinase inhibitor of the rat insulin receptor","volume":"204","author":"Rauth G","year":"1992","unstructured":"Rauth G, P\u00f6schke O, Fink E, et al.. The nucleotide and partial amino acid sequences of rat fetuin: identity with the natural tyrosine kinase inhibitor of the rat insulin receptor. Eur J Biochem. 1992, 204:523-9. 10.1111\/j.1432-1033.1992.tb16663.x","journal-title":"Eur J Biochem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0024-3205(97)00737-6","article-title":"Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase","volume":"61","author":"Mathews ST","year":"1997","unstructured":"Mathews ST, Srinivas PR, Leon MA, Grunberger G. Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase. Life Sci. 1997, 61:1583-92. 10.1016\/s0024-3205(97)00737-6","journal-title":"Life Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001765","article-title":"Fetuin-A induces cytokine expression and suppresses adiponectin production","volume":"3","author":"Hennige AM","year":"2008","unstructured":"Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, H\u00e4ring HU, Stefan N. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One. 2008, 3:e1765. 10.1371\/journal.pone.0001765","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.0587","article-title":"cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant gene transcript 1)","volume":"221","author":"Maeda K","year":"1996","unstructured":"Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant gene transcript 1). Biochem Biophys Res Commun. 1996, 221:286-9. 10.1006\/bbrc.1996.0587","journal-title":"Biochem Biophys Res Commun"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.18.10697","article-title":"AdipoQ is a novel adipose-specific gene dysregulated in obesity","volume":"271","author":"Hu E","year":"1996","unstructured":"Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996, 271:10697-703. 10.1074\/jbc.271.18.10697","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.100.25.2473","article-title":"Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin","volume":"100","author":"Ouchi N","year":"1999","unstructured":"Ouchi N, Kihara S, Arita Y, et al.. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999, 100:2473-6. 10.1161\/01.cir.100.25.2473","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.2007.s143","article-title":"Update on adipocyte hormones: regulation of energy balance and carbohydrate\/lipid metabolism","volume":"53 Suppl 1","author":"Havel PJ","year":"2004","unstructured":"Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate\/lipid metabolism. Diabetes. 2004, 53 Suppl 1:S143-51. 10.2337\/diabetes.53.2007.s143","journal-title":"Diabetes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000099786.99623.EF","article-title":"Adiponectin and metabolic syndrome","volume":"24","author":"Matsuzawa Y","year":"2004","unstructured":"Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004, 24:29-33. 10.1161\/01.ATV.0000099786.99623.EF","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer C","year":"2001","unstructured":"Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001, 86:1930-5. 10.1210\/jcem.86.5.7463","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","article-title":"Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression","volume":"52","author":"Kern PA","year":"2003","unstructured":"Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes. 2003, 52:1779-85.","journal-title":"Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1042\/cs1030137","article-title":"Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population","volume":"103","author":"Yamamoto Y","year":"2002","unstructured":"Yamamoto Y, Hirose H, Saito I, et al.. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond). 2002, 103:137-42. 10.1042\/cs1030137","journal-title":"Clin Sci (Lond)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta K","year":"2000","unstructured":"Hotta K, Funahashi T, Arita Y, et al.. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20:1595-9. 10.1161\/01.atv.20.6.1595","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi T","year":"2001","unstructured":"Yamauchi T, Kamon J, Waki H, et al.. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001, 7:941-6. 10.1038\/90984","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nm724","article-title":"Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30","volume":"8","author":"Maeda N","year":"2002","unstructured":"Maeda N, Shimomura I, Kishida K, et al.. Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30. Nat Med. 2002, 8:731-7. 10.1038\/nm724","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200251200","article-title":"Disruption of adiponectin causes insulin resistance and neointimal formation","volume":"277","author":"Kubota N","year":"2002","unstructured":"Kubota N, Terauchi Y, Yamauchi T, et al.. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002, 277:25863-6. 10.1074\/jbc.C200251200","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.2005","article-title":"Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice","volume":"98","author":"Fruebis J","year":"2001","unstructured":"Fruebis J, Tsao TS, Javorschi S, et al.. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001, 98:2005-10. 10.1073\/pnas.98.4.2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg AH","year":"2001","unstructured":"Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001, 7:947-53. 10.1038\/90992","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI14120","article-title":"Endogenous glucose production is inhibited by the adipose-derived protein Acrp30","volume":"108","author":"Combs TP","year":"2001","unstructured":"Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest. 2001, 108:1875-81. 10.1172\/JCI14120","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi T","year":"2002","unstructured":"Yamauchi T, Kamon J, Minokoshi Y, et al.. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002, 8:1288-95. 10.1038\/nm788","journal-title":"Nat Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.222657499","article-title":"Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation","volume":"99","author":"Tomas E","year":"2002","unstructured":"Tomas E, Tsao TS, Saha AK, et al.. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A. 2002, 99:16309-13. 10.1073\/pnas.222657499","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209033200","article-title":"Globular adiponectin protected ob\/ob mice from diabetes and ApoE-deficient mice from atherosclerosis","volume":"278","author":"Yamauchi T","year":"2003","unstructured":"Yamauchi T, Kamon J, Waki H, et al.. Globular adiponectin protected ob\/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem. 2003, 278:2461-8. 10.1074\/jbc.M209033200","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia U","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, et al.. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020, 21:6275. 10.3390\/ijms21176275","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17202","article-title":"The serum protein \u03b12-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification","volume":"112","author":"Schafer C","year":"2003","unstructured":"Schafer C, Heiss A, Schwarz A, et al.. The serum protein \u03b12-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003, 112:357-66. 10.1172\/JCI17202","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.04.06.dc05-1938","article-title":"\u03b12-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans","volume":"29","author":"Stefan N","year":"2006","unstructured":"Stefan N, Hennige AM, Staiger H, et al.. \u03b12-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 2006, 29:853-7. 10.2337\/diacare.29.04.06.dc05-1938","journal-title":"Diabetes Care"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.814418","article-title":"Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke","volume":"118","author":"Weikert C","year":"2008","unstructured":"Weikert C, Stefan N, Schulze MB, et al.. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation. 2008, 118:2555-62. 10.1161\/CIRCULATIONAHA.108.814418","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0538","article-title":"Plasma fetuin-A levels and the risk of type 2 diabetes","volume":"57","author":"Stefan N","year":"2008","unstructured":"Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, H\u00e4ring HU, Schulze MB. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes. 2008, 57:2762-7. 10.2337\/db08-0538","journal-title":"Diabetes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.01.038","article-title":"The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study","volume":"59","author":"Laughlin GA","year":"2012","unstructured":"Laughlin GA, Cummins KM, Wassel CL, Daniels LB, Ix JH. The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study. J Am Coll Cardiol. 2012, 59:1688-96. 10.1016\/j.jacc.2012.01.038","journal-title":"J Am Coll Cardiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1591","article-title":"Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study","volume":"36","author":"Jensen MK","year":"2013","unstructured":"Jensen MK, Bartz TM, Mukamal KJ, et al.. Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study. Diabetes Care. 2013, 36:1222-8. 10.2337\/dc12-1591","journal-title":"Diabetes Care"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2337\/db17-1268","article-title":"Circulating fetuin-A and risk of type 2 diabetes: a Mendelian randomization analysis","volume":"67","author":"Kr\u00f6ger J","year":"2018","unstructured":"Kr\u00f6ger J, Meidtner K, Stefan N, et al.. Circulating fetuin-A and risk of type 2 diabetes: a Mendelian randomization analysis. Diabetes. 2018, 67:1200-5. 10.2337\/db17-1268","journal-title":"Diabetes"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx091","article-title":"Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium","volume":"26","author":"Jensen MK","year":"2017","unstructured":"Jensen MK, Jensen RA, Mukamal KJ, et al.. Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium. Hum Mol Genet. 2017, 26:2156-63. 10.1093\/hmg\/ddx091","journal-title":"Hum Mol Genet"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.109.870410","article-title":"Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study","volume":"2","author":"Fisher E","year":"2009","unstructured":"Fisher E, Stefan N, Saar K, et al.. Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study. Circ Cardiovasc Genet. 2009, 2:607-13. 10.1161\/CIRCGENETICS.109.870410","journal-title":"Circ Cardiovasc Genet"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal D","year":"2012","unstructured":"Pal D, Dasgupta S, Kundu R, et al.. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 2012, 18:1279-85. 10.1038\/nm.2851","journal-title":"Nat Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3116","article-title":"Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans","volume":"19","author":"Stefan N","year":"2013","unstructured":"Stefan N, H\u00e4ring HU. Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med. 2013, 19:394-5. 10.1038\/nm.3116","journal-title":"Nat Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.08.031","article-title":"Fetuin-A and risk of coronary heart disease: a Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studies","volume":"243","author":"Laugsand LE","year":"2015","unstructured":"Laugsand LE, Ix JH, Bartz TM, et al.. Fetuin-A and risk of coronary heart disease: a Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studies. Atherosclerosis. 2015, 243:44-52. 10.1016\/j.atherosclerosis.2015.08.031","journal-title":"Atherosclerosis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48600-9","article-title":"Fetuin-A and its genetic association with cardiometabolic disease","volume":"13","author":"Al Ali L","year":"2023","unstructured":"Al Ali L, van de Vegte YJ, Said MA, et al.. Fetuin-A and its genetic association with cardiometabolic disease. Sci Rep. 2023, 13:21469. 10.1038\/s41598-023-48600-9","journal-title":"Sci Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.45.26746","article-title":"A novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer PE","year":"1995","unstructured":"Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995, 270:26746-9. 10.1074\/jbc.270.45.26746","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a021483","article-title":"Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma","volume":"120","author":"Nakano Y","year":"1996","unstructured":"Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem. 1996, 120:803-12. 10.1093\/oxfordjournals.jbchem.a021483","journal-title":"J Biochem"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki T","year":"2006","unstructured":"Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006, 116:1784-92. 10.1172\/JCI29126","journal-title":"J Clin Invest"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-013-9283-3","article-title":"Adiponectin and energy homeostasis","volume":"15","author":"Lee B","year":"2014","unstructured":"Lee B, Shao J. Adiponectin and energy homeostasis. Rev Endocr Metab Disord. 2014, 15:149-56. 10.1007\/s11154-013-9283-3","journal-title":"Rev Endocr Metab Disord"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2012.06.008","article-title":"Anti-inflammatory and anti-atherogenic properties of adiponectin","volume":"94","author":"Ohashi K","year":"2012","unstructured":"Ohashi K, Ouchi N, Matsuzawa Y. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 2012, 94:2137-42. 10.1016\/j.biochi.2012.06.008","journal-title":"Biochimie"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.275","article-title":"Analysis of adiponectin gene and comparison of its expression in two different pig breeds","volume":"16","author":"Daniele A","year":"2008","unstructured":"Daniele A, Cammarata R, Masullo M, et al.. Analysis of adiponectin gene and comparison of its expression in two different pig breeds. Obesity (Silver Spring). 2008, 16:1869-74. 10.1038\/oby.2008.275","journal-title":"Obesity (Silver Spring)"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-1039","article-title":"Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects","volume":"169","author":"De Rosa A","year":"2013","unstructured":"De Rosa A, Monaco ML, Capasso M, et al.. Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects. Eur J Endocrinol. 2013, 169:37-43. 10.1530\/EJE-12-1039","journal-title":"Eur J Endocrinol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-1561","article-title":"Plasma adiponectin complexes have distinct biochemical characteristics","volume":"149","author":"Schraw T","year":"2008","unstructured":"Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology. 2008, 149:2270-82. 10.1210\/en.2007-1561","journal-title":"Endocrinology"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.21.2607","article-title":"Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians","volume":"11","author":"Vasseur F","year":"2002","unstructured":"Vasseur F, Helbecque N, Dina C, et al.. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet. 2002, 11:2607-14. 10.1093\/hmg\/11.21.2607","journal-title":"Hum Mol Genet"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.2.536","article-title":"Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population","volume":"51","author":"Hara K","year":"2002","unstructured":"Hara K, Boutin P, Mori Y, et al.. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes. 2002, 51:536-40. 10.2337\/diabetes.51.2.536","journal-title":"Diabetes"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300365200","article-title":"Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin","volume":"278","author":"Waki H","year":"2003","unstructured":"Waki H, Yamauchi T, Kamon J, et al.. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003, 278:40352-63. 10.1074\/jbc.M300365200","journal-title":"J Biol Chem"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.7.2325","article-title":"Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome","volume":"51","author":"Kondo H","year":"2002","unstructured":"Kondo H, Shimomura I, Matsukawa Y, et al.. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes. 2002, 51:2325-8. 10.2337\/diabetes.51.7.2325","journal-title":"Diabetes"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1159\/000172976","article-title":"Molecular analysis of the adiponectin gene in severely obese patients from southern Italy","volume":"53","author":"Daniele A","year":"2008","unstructured":"Daniele A, Cammarata R, Pasanisi F, et al.. Molecular analysis of the adiponectin gene in severely obese patients from southern Italy. Ann Nutr Metab. 2008, 53:155-61. 10.1159\/000172976","journal-title":"Ann Nutr Metab"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345413","article-title":"The absence of polymorphisms in ADRB3, UCP1, PPAR\u03b3, and ADIPOQ genes protects morbid obese patients toward insulin resistance","volume":"35","author":"Bracale R","year":"2012","unstructured":"Bracale R, Labruna G, Finelli C, et al.. The absence of polymorphisms in ADRB3, UCP1, PPAR\u03b3, and ADIPOQ genes protects morbid obese patients toward insulin resistance. J Endocrinol Invest. 2012, 35:2-4. 10.1007\/BF03345413","journal-title":"J Endocrinol Invest"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e318235f206","article-title":"Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: insulin resistance and type 2 diabetes mellitus candidate genes","volume":"20","author":"Berm\u00fadez VJ","year":"2013","unstructured":"Berm\u00fadez VJ, Rojas E, Toledo A, et al.. Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes: insulin resistance and type 2 diabetes mellitus candidate genes. Am J Ther. 2013, 20:414-21. 10.1097\/MJT.0b013e318235f206","journal-title":"Am J Ther"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07851","article-title":"Adiponectin gene polymorphisms associated with diabetes mellitus: a descriptive review","volume":"7","author":"Howlader M","year":"2021","unstructured":"Howlader M, Sultana MI, Akter F, Hossain MM. Adiponectin gene polymorphisms associated with diabetes mellitus: a descriptive review. Heliyon. 2021, 7:e07851. 10.1016\/j.heliyon.2021.e07851","journal-title":"Heliyon"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-291x(03)00940-9","article-title":"Disturbed secretion of mutant adiponectin associated with the metabolic syndrome","volume":"306","author":"Kishida K","year":"2003","unstructured":"Kishida K, Nagaretani H, Kondo H, et al.. Disturbed secretion of mutant adiponectin associated with the metabolic syndrome. Biochem Biophys Res Commun. 2003, 306:286-92. 10.1016\/s0006-291x(03)00940-9","journal-title":"Biochem Biophys Res Commun"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2010.03.062","article-title":"Generation of novel long-acting globular adiponectin molecules","volume":"399","author":"Ge H","year":"2010","unstructured":"Ge H, Xiong Y, Lemon B, et al.. Generation of novel long-acting globular adiponectin molecules. J Mol Biol. 2010, 399:113-9. 10.1016\/j.jmb.2010.03.062","journal-title":"J Mol Biol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1096","article-title":"Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1","volume":"146","author":"Waki H","year":"2005","unstructured":"Waki H, Yamauchi T, Kamon J, et al.. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology. 2005, 146:790-6. 10.1210\/en.2004-1096","journal-title":"Endocrinology"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S22863","article-title":"Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions","volume":"5","author":"Almer G","year":"2011","unstructured":"Almer G, Saba-Lepek M, Haj-Yahya S, et al.. Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions. Biologics. 2011, 5:95-105. 10.2147\/BTT.S22863","journal-title":"Biologics"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-010-0534-2","article-title":"Globular adiponectin regulates energy homeostasis through AMP-activated protein kinase-acetyl-CoA carboxylase (AMPK\/ACC) pathway in the hypothalamus","volume":"344","author":"Wen JP","year":"2010","unstructured":"Wen JP, Liu CE, Hu YT, Chen G, Lin LX. Globular adiponectin regulates energy homeostasis through AMP-activated protein kinase-acetyl-CoA carboxylase (AMPK\/ACC) pathway in the hypothalamus. Mol Cell Biochem. 2010, 344:109-15. 10.1007\/s11010-010-0534-2","journal-title":"Mol Cell Biochem"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin: implications for metabolic regulation and bioactivity","volume":"278","author":"Pajvani UB","year":"2003","unstructured":"Pajvani UB, Du X, Combs TP, et al.. Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin: implications for metabolic regulation and bioactivity. J Biol Chem. 2003, 278:9073-85. 10.1074\/jbc.M207198200","journal-title":"J Biol Chem"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2009.12.021","article-title":"Adiponectin-it's all about the modifications","volume":"42","author":"Simpson F","year":"2010","unstructured":"Simpson F, Whitehead JP. Adiponectin-it's all about the modifications. Int J Biochem Cell Biol. 2010, 42:785-8. 10.1016\/j.biocel.2009.12.021","journal-title":"Int J Biochem Cell Biol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2013.1","article-title":"Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?","volume":"67","author":"Calton EK","year":"2013","unstructured":"Calton EK, Miller VS, Soares MJ. Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?. Eur J Clin Nutr. 2013, 67:485-91. 10.1038\/ejcn.2013.1","journal-title":"Eur J Clin Nutr"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0537","article-title":"Decreased concentration of adiponectin together with a selective reduction of its high molecular weight oligomers is involved in metabolic complications of myotonic dystrophy type 1","volume":"165","author":"Daniele A","year":"2011","unstructured":"Daniele A, De Rosa A, De Cristofaro M, et al.. Decreased concentration of adiponectin together with a selective reduction of its high molecular weight oligomers is involved in metabolic complications of myotonic dystrophy type 1. Eur J Endocrinol. 2011, 165:969-75. 10.1530\/EJE-11-0537","journal-title":"Eur J Endocrinol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2011.12.016","article-title":"Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease","volume":"44","author":"Daniele A","year":"2012","unstructured":"Daniele A, De Rosa A, Nigro E, et al.. Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease. Int J Biochem Cell Biol. 2012, 44:563-9. 10.1016\/j.biocel.2011.12.016","journal-title":"Int J Biochem Cell Biol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2012.01.008","article-title":"Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication","volume":"94","author":"Liu M","year":"2012","unstructured":"Liu M, Liu F. Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication. Biochimie. 2012, 94:2126-30. 10.1016\/j.biochi.2012.01.008","journal-title":"Biochimie"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxm008","article-title":"Comparison of body mass index, waist circumference, and waist\/hip ratio in predicting incident diabetes: a meta-analysis","volume":"29","author":"Vazquez G","year":"2007","unstructured":"Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K. Comparison of body mass index, waist circumference, and waist\/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev. 2007, 29:115-28. 10.1093\/epirev\/mxm008","journal-title":"Epidemiol Rev"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.6.1884","article-title":"Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans","volume":"51","author":"Stefan N","year":"2002","unstructured":"Stefan N, Vozarova B, Funahashi T, et al.. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002, 51:1884-8. 10.2337\/diabetes.51.6.1884","journal-title":"Diabetes"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.8.2015","article-title":"The +276 G\/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients","volume":"27","author":"Bacci S","year":"2004","unstructured":"Bacci S, Menzaghi C, Ercolino T, et al.. The +276 G\/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care. 2004, 27:2015-20. 10.2337\/diacare.27.8.2015","journal-title":"Diabetes Care"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.03.205","article-title":"Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT\/enhancer binding protein-\u03b2 and tumor necrosis factor-\u03b1","volume":"331","author":"Kita A","year":"2005","unstructured":"Kita A, Yamasaki H, Kuwahara H, et al.. Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT\/enhancer binding protein-\u03b2 and tumor necrosis factor-\u03b1. Biochem Biophys Res Commun. 2005, 331:484-90. 10.1016\/j.bbrc.2005.03.205","journal-title":"Biochem Biophys Res Commun"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.6307","article-title":"Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes","volume":"290","author":"Fasshauer M","year":"2002","unstructured":"Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2002, 290:1084-9. 10.1006\/bbrc.2001.6307","journal-title":"Biochem Biophys Res Commun"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201120","article-title":"Association of the human adiponectin gene and insulin resistance","volume":"12","author":"Filippi E","year":"2004","unstructured":"Filippi E, Sentinelli F, Trischitta V, et al.. Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet. 2004, 12:199-205. 10.1038\/sj.ejhg.5201120","journal-title":"Eur J Hum Genet"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480293","article-title":"The role of the novel adipocyte-derived hormone adiponectin in human disease","volume":"148","author":"D\u00edez JJ","year":"2003","unstructured":"D\u00edez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003, 148:293-300. 10.1530\/eje.0.1480293","journal-title":"Eur J Endocrinol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan N","year":"2023","unstructured":"Stefan N, Schick F, Birkenfeld AL, H\u00e4ring HU, White MF. The role of hepatokines in NAFLD. Cell Metab. 2023, 35:236-52. 10.1016\/j.cmet.2023.01.006","journal-title":"Cell Metab"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1097\/JIM.0000000000000151","article-title":"Association of human fetuin-A rs4917 polymorphism with obesity in 2 cohorts","volume":"63","author":"Temesszentandr\u00e1si G","year":"2015","unstructured":"Temesszentandr\u00e1si G, V\u00f6r\u00f6s K, B\u00f6r\u00f6cz Z, et al.. Association of human fetuin-A rs4917 polymorphism with obesity in 2 cohorts. J Investig Med. 2015, 63:548-53. 10.1097\/JIM.0000000000000151","journal-title":"J Investig Med"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.05.011","article-title":"Association of the adiponectin gene rs1501299 G>T variant, serum adiponectin levels, and the risk of coronary artery disease in a Chinese population","volume":"97","author":"Gui MH","year":"2012","unstructured":"Gui MH, Li X, Jiang SF, Gao J, Lu DR, Gao X. Association of the adiponectin gene rs1501299 G>T variant, serum adiponectin levels, and the risk of coronary artery disease in a Chinese population. Diabetes Res Clin Pract. 2012, 97:499-504. 10.1016\/j.diabres.2012.05.011","journal-title":"Diabetes Res Clin Pract"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq423","article-title":"Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ","volume":"19","author":"Wu Y","year":"2010","unstructured":"Wu Y, Li Y, Lange EM, et al.. Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet. 2010, 19:4955-64. 10.1093\/hmg\/ddq423","journal-title":"Hum Mol Genet"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-020-01251-5","article-title":"Fetuin-a to adiponectin ratio is a sensitive indicator for evaluating metabolic syndrome in the elderly","volume":"19","author":"Zhou Z","year":"2020","unstructured":"Zhou Z, Sun M, Jin H, Chen H, Ju H. Fetuin-a to adiponectin ratio is a sensitive indicator for evaluating metabolic syndrome in the elderly. Lipids Health Dis. 2020, 19:61. 10.1186\/s12944-020-01251-5","journal-title":"Lipids Health Dis"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study","volume":"361","author":"Ketteler M","year":"2003","unstructured":"Ketteler M, Bongartz P, Westenfeld R, et al.. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 2003, 361:827-33. 10.1016\/S0140-6736(03)12710-9","journal-title":"Lancet"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.588723","article-title":"Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study","volume":"113","author":"Ix JH","year":"2006","unstructured":"Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation. 2006, 113:1760-7. 10.1161\/CIRCULATIONAHA.105.588723","journal-title":"Circulation"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2008.00069.x","article-title":"Adiponectin, an unlocking adipocytokine","volume":"27","author":"Sun Y","year":"2009","unstructured":"Sun Y, Xun K, Wang C, Zhao H, Bi H, Chen X, Wang Y. Adiponectin, an unlocking adipocytokine. Cardiovasc Ther. 2009, 27:59-75. 10.1111\/j.1755-5922.2008.00069.x","journal-title":"Cardiovasc Ther"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0235","article-title":"The association of adiponectin with risk of pre-diabetes and diabetes in different subgroups: cluster analysis of a general population in south China","volume":"10","author":"Gong X","year":"2021","unstructured":"Gong X, You L, Li F, et al.. The association of adiponectin with risk of pre-diabetes and diabetes in different subgroups: cluster analysis of a general population in south China. Endocr Connect. 2021, 10:1410-9. 10.1530\/EC-21-0235","journal-title":"Endocr Connect"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki T","year":"2005","unstructured":"Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005, 26:439-51. 10.1210\/er.2005-0005","journal-title":"Endocr Rev"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2016-000194","article-title":"Adiponectin levels predict prediabetes risk: the Pathobiology of Prediabetes in A Biracial Cohort (POP-ABC) study","volume":"4","author":"Jiang Y","year":"2016","unstructured":"Jiang Y, Owei I, Wan J, Ebenibo S, Dagogo-Jack S. Adiponectin levels predict prediabetes risk: the Pathobiology of Prediabetes in A Biracial Cohort (POP-ABC) study. BMJ Open Diabetes Res Care. 2016, 4:e000194. 10.1136\/bmjdrc-2016-000194","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2016.10.006","article-title":"Role of serum adiponectin and vitamin D in prediabetes and diabetes mellitus","volume":"41","author":"Banerjee A","year":"2017","unstructured":"Banerjee A, Khemka VK, Roy D, Poddar J, Roy TK, Karnam SA. Role of serum adiponectin and vitamin D in prediabetes and diabetes mellitus. Can J Diabetes. 2017, 41:259-65. 10.1016\/j.jcjd.2016.10.006","journal-title":"Can J Diabetes"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.4103\/jod.jod_86_22","article-title":"Association of circulatory adiponectin with the parameters of Madras Diabetes Research Foundation-Indian Diabetes Risk Score","volume":"13","author":"Khan MD","year":"2022","unstructured":"Khan MD, Ahmad MK, Alam R,  Khan S, Jaiswal G, Khan MM. Association of circulatory adiponectin with the parameters of Madras Diabetes Research Foundation-Indian Diabetes Risk Score. J Diabetol. 2022, 13:331-9. 10.4103\/jod.jod_86_22","journal-title":"J Diabetol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303257835231117062928","article-title":"A systematic narrative review on ADIPOQ gene variants and its association with T2DM in the Indian population","volume":"24","author":"Khan MD","year":"2024","unstructured":"Khan MD, Srivastava RK, Upadhyay TK, Khan MM. A systematic narrative review on ADIPOQ gene variants and its association with T2DM in the Indian population. Endocr Metab Immune Disord Drug Targets. 2024, 24:1161-8. 10.2174\/0118715303257835231117062928","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref89","article-title":"Association of adiponectin & T-cadherin with cardiovascular disease - a review article","volume":"12","author":"Khan MD","year":"2021","unstructured":"Khan MD, Ahmad MK, Raj P, Khan MM. Association of adiponectin & T-cadherin with cardiovascular disease - a review article. J Cardiovasc Dis Res. 2021, 12:1862-8.","journal-title":"J Cardiovasc Dis Res"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1505","article-title":"Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss","volume":"93","author":"Reinehr T","year":"2008","unstructured":"Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab. 2008, 93:4479-85. 10.1210\/jc.2008-1505","journal-title":"J Clin Endocrinol Metab"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2008.04.019","article-title":"Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus","volume":"57","author":"Mori K","year":"2008","unstructured":"Mori K, Emoto M, Araki T, et al.. Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus. Metabolism. 2008, 57:1248-52. 10.1016\/j.metabol.2008.04.019","journal-title":"Metabolism"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0148","article-title":"Elevated fetuin-A concentrations in morbid obesity decrease after dramatic weight loss","volume":"95","author":"Brix JM","year":"2010","unstructured":"Brix JM, Stingl H, H\u00f6llerl F, Schernthaner GH, Kopp HP, Schernthaner G. Elevated fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab. 2010, 95:4877-81. 10.1210\/jc.2010-0148","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/341056-role-of-the-genetic-variants-of-fetuin-a-and-adiponectin-in-type-2-diabetes-mellitus-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:39:10Z","timestamp":1762033150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/341056-role-of-the-genetic-variants-of-fetuin-a-and-adiponectin-in-type-2-diabetes-mellitus-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":92,"URL":"https:\/\/doi.org\/10.7759\/cureus.95914","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]}}}